Abstract
Idiopathic intracranial hypertension is a neurological syndrome determined by a rise in intracranial pressure without a detectable cause. Course and prognosis may be changeable, requiring a multidisciplinary approach for its diagnosis and management. Although its precise pathogenesis is still unknown, many studies have been carried out to define the possible causal and associated factors, such as retinoids, steroid hormones, body mass index and recent weight gains, cytokines and adipokines levels. The clinical presentation can be variable including chronic headache, disturbance of vision, diplopia and tinnitus. Even if papilloedema is considered the most specific sign, it could not be observed in more than 5% of patients during the evaluation of the fundus oculi. Neuroradiological signs acquire greater importance in patients who do not present papilloedema and may suggest the diagnosis of idiopathic intracranial hypertension. Other assessments can be useful in the diagnostic process, such as optical coherence tomography, visual evoked potentials, ocular ultrasonography and fundus fluorescein angiography and autofluorescence. Nonetheless, cerebrospinal fluid pressure measurement is required to establish a definite diagnosis. Management may be different, since surgical procedures or lumbar punctures are often required when symptoms develop rapidly leading to a loss of visual function. Apart from these cases, patients can be treated with a pharmacological approach and low-calorie diet, but they also need to be monitored over time since relapses years later are not uncommon.
Similar content being viewed by others
References
Chen J, Wall M (2014) Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin 54:1–11. https://doi.org/10.1097/IIO.0b013e3182aabf11
Yabe I, Moriwaka F, Notoya A et al (2000) Incidence of idiopathic intracranial hypertension in Hokkaido, the northernmost island of Japan. J Neurol 247:474–475
Ng M, Fleming T, Robinson M et al (2014) Global, regional and national prevalence of overweight and obesity in children and adults 1980–2013: a systematic analysis. Lancet 384:766–781. https://doi.org/10.1016/S0140-6736(14)60460-8
Bruce BB, Kedar S, Van Stavern GP et al (2009) Idiopathic intracranial hypertension in men. Neurology 72:304–309. https://doi.org/10.1212/01.wnl.0000333254.84120.f5
Cleves-Bayon C (2018) Idiopathic intracranial hypertension in children and adolescents: an update. Headache 58:485–493. https://doi.org/10.1111/head.13236
Daniels AB, Liu GT, Volpe NJ et al (2007) Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (Pseudotumor cerebri). Am J Ophthalmol 143:635–641. https://doi.org/10.1016/j.ajo.2006.12.040
Szewka AJ, Bruce BB, Newman NJ, Biousse V (2013) Idiopathic intracranial hypertension: relation between obesity and visual outcomes. J Neuroophthalmol 33:4–8. https://doi.org/10.1097/WNO.0b013e31823f852d
Ko MW, Chang SC, Ridha MA et al (2011) Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology 76:1564–1567. https://doi.org/10.1212/WNL.0b013e3182190f51
Sugerman HJ, DeMaria EJ, Felton WL et al (1997) Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated Pseudotumor cerebri. Neurology 49:507–511
Kesler A, Kliper E, Shenkerman G, Stern N (2010) Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology 117:169–174. https://doi.org/10.1016/j.ophtha.2009.06.030
Kesler A, Kliper E, Assayag EB et al (2010) Thrombophilic factors in idiopathic intracranial hypertension: a report of 51 patients and a meta-analysis. Blood Coagul Fibrinolysis 21:328–333. https://doi.org/10.1097/MBC.0b013e328338ce12
Markey KA, Uldall M, Botfield H et al (2016) Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases. J Pain Res 9:223–232. https://doi.org/10.2147/JPR.S80824
Botfield HF, Uldall MS, Westgate CSJ et al (2017) A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aan0972
ISRCTN - ISRCTN12678718: IIH Pressure—a new treatment for raised brain pressure in Idiopathic Intracranial Hypertension. https://www.isrctn.com/ISRCTN12678718. Accessed 19 Nov 2019
Mitchell JL, Mollan SP, Vijay V, Sinclair AJ (2019) Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension. Curr Opin Neurol 32:422–431. https://doi.org/10.1097/WCO.0000000000000690
Toscano V, Sancesario G, Bianchi P et al (1991) Cerebrospinal fluid estrone in Pseudotumor cerebri: a change in cerebral steroid hormone metabolism? J Endocrinol Invest 14:81–86. https://doi.org/10.1007/BF03350271
Klein A, Stern N, Osher E et al (2013) Hyperandrogenism is associated with earlier age of onset of idiopathic intracranial hypertension in women. Curr Eye Res 38:972–976. https://doi.org/10.3109/02713683.2013.799214
Sinclair AJ, Walker EA, Burdon MA et al (2010) Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation? J Clin Endocrinol Metab 95:5348–5356. https://doi.org/10.1210/jc.2010-0729
Safety and effectiveness of 11b-hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) to treat idiopathic intracranial hypertension.—Full Text View—ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02017444. Accessed 19 Nov 2019
Thurtell MJ, Trotti LM, Bixler EO et al (2013) Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data. J Neurol 260:1748–1751. https://doi.org/10.1007/s00415-013-6858-6
Wall M, Purvin V (2009) Idiopathic intracranial hypertension in men and the relationship to sleep apnea. Neurology 72:300–301. https://doi.org/10.1212/01.wnl.0000336338.97703.fb
Onder H, Aksoy M (2019) Resolution of idiopathic intracranial hypertension symptoms by surgery for obstructive sleep apnea in a pediatric patient. J Pediatr Neurosci 14:110–112. https://doi.org/10.4103/jpn.JPN_30_19
Umenishi F, Schrier RW (2002) Induction of human aquaporin-1 gene by retinoic acid in human erythroleukemia HEL cells. Biochem Biophys Res Commun 293:913–917. https://doi.org/10.1016/S0006-291X(02)00316-9
Warner JEA, Larson AJ, Bhosale P et al (2007) Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol 27:258–262. https://doi.org/10.1097/WNO.0b013e31815b9af0
Tabassi A, Salmasi AH, Jalali M (2005) Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology 64:1893–1896. https://doi.org/10.1212/01.WNL.0000163556.31080.98
Jacobson DM, Berg R, Wall M et al (1999) Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology 53:1114–1118
Libien J, Kupersmith MJ, Blaner W et al (2017) Role of vitamin A metabolism in IIH: results from the idiopathic intracranial hypertension treatment trial. J Neurol Sci 372:78–84. https://doi.org/10.1016/j.jns.2016.11.014
Giuseffi V, Wall M, Siegel PZ, Rojas PB (1991) Symptoms and disease associations in idiopathic intracranial hypertension (Pseudotumor cerebri): a case-control study. Neurology 41:239–244
Wysowski DK, Green L (1995) Serious adverse events in Norplant users reported to the food and drug administration’s MedWatch Spontaneous Reporting System. Obstet Gynecol 85:538–542. https://doi.org/10.1016/0029-7844(94)00457-O
Valenzuela RM, Rai R, Kirk BH et al (2017) An estimation of the risk of Pseudotumor cerebri among users of the Levonorgestrel intrauterine device. Neuroophthalmology 41:192–197. https://doi.org/10.1080/01658107.2017.1304425
Radhakrishnan K, Thacker AK, Bohlaga NH et al (1993) Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci 116:18–28. https://doi.org/10.1016/0022-510x(93)90084-c
Kilgore KP, Lee MS, Leavitt JA et al (2019) A population-based, case-control evaluation of the association between hormonal contraceptives and idiopathic intracranial hypertension. Am J Ophthalmol 197:74–79. https://doi.org/10.1016/j.ajo.2018.09.014
Mollan SP, Davies B, Silver NC et al (2018) Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry 89:1088–1100. https://doi.org/10.1136/jnnp-2017-317440
Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ (1996) Elevated intracranial venous pressure as a universal mechanism in Pseudotumor cerebri of varying etiologies. Neurology 46:198–202
Hirsch N (2013) Cerebrospinal fluid and its physiology. Anaesth Intensive Care Med 14:379–380. https://doi.org/10.1016/j.mpaic.2013.06.001
Higgins JNP, Gillard JH, Owler BK et al (2004) MR venography in idiopathic intracranial hypertension: unappreciated and misunderstood. J Neurol Neurosurg Psychiatry 75:621–625
Farb RI, Vanek I, Scott JN et al (2003) Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60:1418–1424. https://doi.org/10.1212/01.wnl.0000066683.34093.e2
Fera F, Bono F, Messina D et al (2005) Comparison of different MR venography techniques for detecting transverse sinus stenosis in idiopathic intracranial hypertension. J Neurol 252:1021–1025. https://doi.org/10.1007/s00415-005-0710-6
Pickard JD, Czosnyka Z, Czosnyka M et al (2008) Coupling of sagittal sinus pressure and cerebrospinal fluid pressure in idiopathic intracranial hypertension–a preliminary report. Acta Neurochir Suppl 102:283–285
Liu X, Di H, Wang J et al (2019) Endovascular stenting for idiopathic intracranial hypertension with venous sinus stenosis. Brain Behav 9:e01279. https://doi.org/10.1002/brb3.1279
Dinkin MJ, Patsalides A (2017) Venous sinus stenting in idiopathic intracranial hypertension: results of a prospective trial. J Neuroophthalmol 37:113–121. https://doi.org/10.1097/WNO.0000000000000426
Ahmed RM, Wilkinson M, Parker GD et al (2011) Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol 32:1408–1414. https://doi.org/10.3174/ajnr.A2575
De Simone R, Ranieri A, Sansone M et al (2019) Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine. Neurol Sci 40:59–70. https://doi.org/10.1007/s10072-019-03775-w
Ahmed R, Friedman DI, Halmagyi GM (2011) Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol 31:374–380. https://doi.org/10.1097/WNO.0b013e318237eb73
De Simone R, Marano E, Fiorillo C et al (2005) Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci 25:342–344. https://doi.org/10.1007/s10072-004-0368-3
Abubaker K, Ali Z, Raza K et al (2011) Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts–case series and literature review. Br J Neurosurg 25:94–99. https://doi.org/10.3109/02688697.2010.544781
Iencean SM, Iencean AS (2016) Vascular etiology of intracranial hypertension. Kaohsiung J Med Sci 32:389–390. https://doi.org/10.1016/j.kjms.2016.04.006
Türay S, Kabakuş N, Hanci F et al (2019) Cause or consequence: the relationship between cerebral venous thrombosis and idiopathic intracranial hypertension. Neurologist 24:155–160. https://doi.org/10.1097/NRL.0000000000000242
de Bezerra MLS, de Ferreira ACAF, de Oliveira-Souza R (2018) Pseudotumor cerebri and glymphatic dysfunction. Front Neurol. https://doi.org/10.3389/fneur.2017.00734
Lenck S, Radovanovic I, Nicholson P et al (2018) Idiopathic intracranial hypertension: the veno glymphatic connections. Neurology 91:515–522. https://doi.org/10.1212/WNL.0000000000006166
Benveniste H, Lee H, Volkow ND (2017) The Glymphatic pathway: waste removal from the CNS via cerebrospinal fluid transport. Neuroscientist 23:454–465. https://doi.org/10.1177/1073858417691030
O’Reilly MW, Westgate CS, Hornby C et al (2019) A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. https://doi.org/10.1172/jci.insight.125348
Adderley NJ, Subramanian A, Nirantharakumar K et al (2019) Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2019.1812
Puustinen T, Tervonen J, Avellan C et al (2019) Psychiatric disorders are a common prognostic marker for worse outcome in patients with idiopathic intracranial hypertension. Clin Neurol Neurosurg 186:105527. https://doi.org/10.1016/j.clineuro.2019.105527
Mollan SP, Hoffmann J, Sinclair AJ (2019) Advances in the understanding of headache in idiopathic intracranial hypertension. Curr Opin Neurol 32:92–98. https://doi.org/10.1097/WCO.0000000000000651
De Simone R, Ranieri A, Fiorillo C et al (2010) Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression? Neurol Sci 31:411–415. https://doi.org/10.1007/s10072-010-0229-1
May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12:455–464. https://doi.org/10.1038/nrneurol.2016.93
Chen J, Wall M (2014) Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin. https://doi.org/10.1097/IIO.0b013e3182aabf11
Friedman DI, Quiros PA, Subramanian PS et al (2017) Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache 57:1195–1205. https://doi.org/10.1111/head.13153
De Simone R, Ranieri A, Cardillo G, Bonavita V (2011) High prevalence of bilateral transverse sinus stenosis-associated IIHWOP in unresponsive chronic headache sufferers: pathogenetic implications in primary headache progression. Cephalalgia 31:763–765. https://doi.org/10.1177/0333102411399350
Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629–808. https://doi.org/10.1177/0333102413485658
Curone M, Tullo V, Bussone G (2019) Headache attributed to IIH: clinical evolution in IHS criteria through the years. Neurol Sci 40:55–58. https://doi.org/10.1007/s10072-019-03795-6
Wall M, Kupersmith MJ, Kieburtz KD et al (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71:693–701. https://doi.org/10.1001/jamaneurol.2014.133
Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9–160. https://doi.org/10.1111/j.1468-2982.2003.00824.x
Ball AK, Clarke CE (2006) Idiopathic intracranial hypertension. Lancet Neurol 5:433–442. https://doi.org/10.1016/S1474-4422(06)70442-2
Mollan SP, Ali F, Hassan-Smith G et al (2016) Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry 87:982–992. https://doi.org/10.1136/jnnp-2015-311302
Haywood KL, Mars TS, Potter R et al (2018) Assessing the impact of headaches and the outcomes of treatment: a systematic review of patient-reported outcome measures (PROMs). Cephalalgia 38:1374–1386. https://doi.org/10.1177/0333102417731348
Wall M, Subramani A, Chong LX et al (2019) Threshold static automated perimetry of the full visual field in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 60:1898–1905. https://doi.org/10.1167/iovs.18-26252
Sadun AA, Currie JN, Lessell S (1984) Transient visual obscurations with elevated optic discs. Ann Neurol 16:489–494. https://doi.org/10.1002/ana.410160410
Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the Pseudotumor cerebri syndrome in adults and children. Neurology 81:1159–1165. https://doi.org/10.1212/WNL.0b013e3182a55f17
Samancı B, Samancı Y, Şen C et al (2019) Assessment of the olfactory function in patients with idiopathic intracranial hypertension using the Sniffin’ sticks test: a case-control study. Headache 59:848–857. https://doi.org/10.1111/head.13538
Zur D, Naftaliev E, Kesler A (2015) Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. J Neuroophthalmol 35:26–30. https://doi.org/10.1097/WNO.0000000000000199
Campbell WW, DeJong RN (2005) DeJong’s the neurologic examination. Lippincott Williams & Wilkins, Philadelphia
Visa Reñé N, Paredes Carmona F (2019) Pseudo-Foster Kennedy syndrome due to idiopathic intracranial hypertension. Arch Soc Esp Oftalmol. https://doi.org/10.1016/j.oftal.2019.09.006
Mollan SP, Markey KA, Benzimra JD et al (2014) A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension. Pract Neurol 14:380–390. https://doi.org/10.1136/practneurol-2014-000821
Digre KB, Nakamoto BK, Warner JEA et al (2009) A comparison of idiopathic intracranial hypertension with and without papilledema. Headache 49:185–193. https://doi.org/10.1111/j.1526-4610.2008.01324.x
Manjubashini D, Kiran M, Akshaya S, Nagarajan K (2019) Intrasphenoidal encephalocele with spontaneous cerebrospinal fluid rhinorrhea in idiopathic intracranial hypertension: need for clarity in terminology and imaging delineation. World Neurosurg 132:129–133. https://doi.org/10.1016/j.wneu.2019.08.186
Pérez MA, Bialer OY, Bruce BB et al (2013) Primary spontaneous cerebrospinal fluid leaks and idiopathic intracranial hypertension. J Neuroophthalmol 33:330–337. https://doi.org/10.1097/WNO.0b013e318299c292
Tam EK, Gilbert AL (2019) Spontaneous cerebrospinal fluid leak and idiopathic intracranial hypertension. Curr Opin Ophthalmol 30:467–471. https://doi.org/10.1097/ICU.0000000000000603
Maralani PJ, Hassanlou M, Torres C et al (2012) Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension. Clin Radiol 67:656–663. https://doi.org/10.1016/j.crad.2011.12.002
Mallery RM, Rehmani OF, Woo JH et al (2019) Utility of magnetic resonance imaging features for improving the diagnosis of idiopathic intracranial hypertension without papilledema. J Neuroophthalmol 39:299–307. https://doi.org/10.1097/WNO.0000000000000767
Zetchi A, Labeyrie M-A, Nicolini E et al (2019) Empty sella is a sign of symptomatic lateral sinus stenosis and not intracranial hypertension. AJNR Am J Neuroradiol 40:1695–1700. https://doi.org/10.3174/ajnr.A6210
Auer MK, Stieg MR, Crispin A et al (2018) Primary empty sella syndrome and the prevalence of hormonal dysregulation. Dtsch Arztebl Int 115:99–105. https://doi.org/10.3238/arztebl.2018.0099
Kwee RM, Kwee TC (2019) Systematic review and meta-analysis of MRI signs for diagnosis of idiopathic intracranial hypertension. Eur J Radiol 116:106–115. https://doi.org/10.1016/j.ejrad.2019.04.023
Agid R, Farb RI, Willinsky RA et al (2006) Idiopathic intracranial hypertension: the validity of cross-sectional neuroimaging signs. Neuroradiology 48:521–527. https://doi.org/10.1007/s00234-006-0095-y
Delen F, Peker E, Onay M et al (2019) The significance and reliability of imaging findings in Pseudotumor cerebri. Neuroophthalmology 43:81–90. https://doi.org/10.1080/01658107.2018.1493514
Wong H, Sanghera K, Neufeld A et al (2019) Clinico-radiological correlation of magnetic resonance imaging findings in patients with idiopathic intracranial hypertension. Neuroradiology. https://doi.org/10.1007/s00234-019-02288-9
Rehder D (2019) Idiopathic intracranial hypertension: review of clinical syndrome, imaging findings, and treatment. Curr Probl Diagn Radiol. https://doi.org/10.1067/j.cpradiol.2019.02.012
Hu R, Holbrook J, Newman NJ et al (2019) Cerebrospinal fluid pressure reduction results in dynamic changes in optic nerve angle on magnetic resonance imaging. J Neuroophthalmol 39:35–40. https://doi.org/10.1097/WNO.0000000000000643
Golden E, Krivochenitser R, Mathews N et al (2019) Contrast-enhanced 3D-FLAIR imaging of the optic nerve and optic nerve head: novel neuroimaging findings of idiopathic intracranial hypertension. AJNR Am J Neuroradiol 40:334–339. https://doi.org/10.3174/ajnr.A5937
Farrokhi Y, Sharif Kashani S, Aghsaei Fard M et al (2019) Optic canal size in idiopathic intracranial hypertension and asymmetric papilledema. Clin Neurol Neurosurg 184:105376. https://doi.org/10.1016/j.clineuro.2019.105376
Bono F, Messina D, Giliberto C et al (2006) Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology 67:419–423. https://doi.org/10.1212/01.wnl.0000227892.67354.85
Bono F, Messina D, Giliberto C et al (2008) Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J Neurol 255:807–812. https://doi.org/10.1007/s00415-008-0676-2
Bono F, Cristiano D, Mastrandrea C et al (2010) The upper limit of normal CSF opening pressure is related to bilateral transverse sinus stenosis in headache sufferers. Cephalalgia 30:145–151. https://doi.org/10.1111/j.1468-2982.2009.01896.x
Ihsclassification 7.1.1 Headache attributed to idiopathic intracranial hypertension (IIH). In: ICHD-3 the international classification of headache disorders 3rd edition. https://www.ichd-3.org/7-headache-attributed-to-non-vascular-intracranial-disorder/7-1-headache-attributed-to-increased-cerebrospinal-fluid-pressure/7-1-1-headache-attributed-to-idiopathic-intracranial-hypertension-iih/. Accessed 15 Apr 2018
Morisaki Y, Nakagawa I, Omoto K et al (2019) Endovascular treatment of idiopathic intracranial hypertension caused by multiple venous sinus stenoses. Surg Neurol Int. https://doi.org/10.25259/SNI-94-2019
Hedjoudje A, Piveteau A, Gonzalez-Campo C et al (2019) The occipital emissary vein: a possible marker for Pseudotumor cerebri. AJNR Am J Neuroradiol 40:973–978. https://doi.org/10.3174/ajnr.A6061
Butros SR, Goncalves LF, Thompson D et al (2012) Imaging features of idiopathic intracranial hypertension, including a new finding: widening of the foramen ovale. Acta Radiol 53:682–688. https://doi.org/10.1258/ar.2012.110705
Julayanont P, Karukote A, Ruthirago D et al (2016) Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects. J Pain Res 9:87–99. https://doi.org/10.2147/JPR.S60633
Sarica A, Curcio M, Rapisarda L et al (2019) Periventricular white matter changes in idiopathic intracranial hypertension. Ann Clin Transl Neurol 6:233–242. https://doi.org/10.1002/acn3.685
Batur Caglayan HZ, Ucar M, Hasanreisoglu M et al (2019) Magnetic resonance imaging of idiopathic intracranial hypertension: before and after treatment. J Neuroophthalmol 39:324–329. https://doi.org/10.1097/WNO.0000000000000792
Hoffmann J, Mollan SP, Paemeleire K et al (2018) European headache federation guideline on idiopathic intracranial hypertension. J Headache Pain 19:93. https://doi.org/10.1186/s10194-018-0919-2
Sengupta S, Eckstein C, Collins T (2019) The dilemma of diagnosing idiopathic intracranial hypertension without papilledema in patients with chronic migraine. JAMA Neurol 76:1001–1002. https://doi.org/10.1001/jamaneurol.2019.1696
Eide PK, Kerty E (2011) Static and pulsatile intracranial pressure in idiopathic intracranial hypertension. Clin Neurol Neurosurg 113:123–128. https://doi.org/10.1016/j.clineuro.2010.10.008
Eide PK, Sorteberg W (2008) Changes in intracranial pulse pressure amplitudes after shunt implantation and adjustment of shunt valve opening pressure in normal pressure hydrocephalus. Acta Neurochir (Wien) 150:1141–1147. https://doi.org/10.1007/s00701-008-0138-8
Giliberto C, Mostile G, Lo Fermo S et al (2017) Vascular parkinsonism or idiopathic NPH? New insights from CSF pressure analysis. Neurol Sci 38:2209–2212. https://doi.org/10.1007/s10072-017-3093-4
Eide PK, Sorteberg W (2006) Intracranial pressure levels and single wave amplitudes, Glasgow Coma Score and Glasgow Outcome Score after subarachnoid haemorrhage. Acta Neurochir (Wien) 148:1267–1275. https://doi.org/10.1007/s00701-006-0908-0
Czosnyka M, Pickard JD (2004) Monitoring and interpretation of intracranial pressure. J Neurol Neurosurg Psychiatry 75:813–821
Czosnyka Z, Czosnyka M (2017) Long-term monitoring of intracranial pressure in normal pressure hydrocephalus and other CSF disorders. Acta Neurochir (Wien) 159:1979–1980. https://doi.org/10.1007/s00701-017-3282-1
Lundberg N (1960) Continuous recording and control of ventricular fluid pressure in neurosurgical practice. Acta Psychiatr Scand Suppl 36:1–193
Torbey MT, Geocadin RG, Razumovsky AY et al (2004) Utility of CSF pressure monitoring to identify idiopathic intracranial hypertension without papilledema in patients with chronic daily headache. Cephalalgia 24:495–502. https://doi.org/10.1111/j.1468-2982.2004.00688.x
Bono F, Curcio M, Rapisarda L et al (2018) Cerebrospinal fluid pressure-related features in chronic headache: a prospective study and potential diagnostic implications. Front Neurol 9:1090. https://doi.org/10.3389/fneur.2018.01090
Funnell JP, Craven CL, D’Antona L et al (2018) Intracranial pressure in patients with papilloedema. Acta Neurol Scand 138:137–142. https://doi.org/10.1111/ane.12922
Fleischman D, Kaskar O, Shams R et al (2019) A novel porcine model for the study of cerebrospinal fluid dynamics: development and preliminary results. Front Neurol 10:1137. https://doi.org/10.3389/fneur.2019.01137
Skau M, Yri H, Sander B et al (2013) Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 251:567–574. https://doi.org/10.1007/s00417-012-2039-z
Scott CJ, Kardon RH, Lee AG et al (2010) Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol 128:705–711. https://doi.org/10.1001/archophthalmol.2010.94
Albrecht P, Blasberg C, Ringelstein M et al (2017) Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J Neurol 264:1370–1380. https://doi.org/10.1007/s00415-017-8532-x
Athappilly G, García-Basterra I, Machado-Miller F et al (2018) Ganglion cell complex analysis as a potential indicator of early neuronal loss in idiopathic intracranial hypertension. Neuroophthalmology 43:10–17. https://doi.org/10.1080/01658107.2018.1476558
Optical Coherence Tomography Substudy Committee, NORDIC Idiopathic Intracranial Hypertension Study Group (2015) Papilledema outcomes from the optical coherence tomography substudy of the idiopathic intracranial hypertension treatment trial. Ophthalmology 122:1939–1945.e2. https://doi.org/10.1016/j.ophtha.2015.06.003
Rougier M-B, Le Goff M, Korobelnik J-F (2018) Optical coherence tomography angiography at the acute phase of optic disc edema. Eye Vis (Lond) 5:15. https://doi.org/10.1186/s40662-018-0109-y
Tüntaş Bilen F, Atilla H (2019) Peripapillary vessel density measured by optical coherence tomography angiography in idiopathic intracranial hypertension. J Neuroophthalmol 39:319–323. https://doi.org/10.1097/WNO.0000000000000745
Tai TYT (2018) Visual evoked potentials and glaucoma. Asia Pac J Ophthalmol (Phila). https://doi.org/10.22608/APO.2017532
Kesler A, Vakhapova V, Korczyn AD, Drory VE (2009) Visual evoked potentials in idiopathic intracranial hypertension. Clin Neurol Neurosurg 111:433–436. https://doi.org/10.1016/j.clineuro.2008.12.008
Hamamci M, Tombul T (2019) Visual evoked potentials follow-up in idiopathic intracranial hypertension. Neurosciences (Riyadh) 24:185–191. https://doi.org/10.17712/nsj.2019.3.20190004
Jeub M, Schlapakow E, Ratz M et al (2019) Sonographic assessment of the optic nerve and the central retinal artery in idiopathic intracranial hypertension. J Clin Neurosci. https://doi.org/10.1016/j.jocn.2019.09.003
Rehman H, Khan MS, Nafees M et al (2016) Optic nerve sheath diameter on sonography in idiopathic intracranial hypertension versus normal. J Coll Physicians Surg Pak 26:758–760
Messerer M, Berhouma M, Messerer R, Dubourg J (2013) Interest of optic nerve sheath diameter ultrasonography in dectecting non-invasively raised intracranial pressure. Neurochirurgie 59:55–59. https://doi.org/10.1016/j.neuchi.2013.02.001
Dubourg J, Javouhey E, Geeraerts T et al (2011) Ultrasonography of optic nerve sheath diameter for detection of raised intracranial pressure: a systematic review and meta-analysis. Intensive Care Med 37:1059–1068. https://doi.org/10.1007/s00134-011-2224-2
Naldi A, Provero P, Vercelli A et al (2019) Optic nerve sheath diameter asymmetry in healthy subjects and patients with intracranial hypertension. Neurol Sci. https://doi.org/10.1007/s10072-019-04076-y
Malamos P, Masaoutis P, Georgalas I et al (2015) The role of fundus autofluorescence imaging in the study of the course of posterior uveitis disorders. Biomed Res Int. https://doi.org/10.1155/2015/247469
Dandy WE (1937) Intracranial pressure without brain tumor. Ann Surg 106:492–513
Smith JL (1985) Whence Pseudotumor cerebri? J Clin Neuroophthalmol 5:55–56
Friedman DI, Jacobson DM (2002) Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59:1492–1495
Wall M, Corbett JJ (2014) Revised diagnostic criteria for the Pseudotumor cerebri syndrome in adults and children response. Neurology 83:198–200. https://doi.org/10.1212/01.wnl.0000452039.32455.3e
Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl 7):1–96
Yri HM, Jensen RH (2015) Idiopathic intracranial hypertension: clinical nosography and field-testing of the ICHD diagnostic criteria. A case-control study. Cephalalgia 35:553–562. https://doi.org/10.1177/0333102414550109
Sinclair AJ, Burdon MA, Nightingale PG et al (2010) Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 341:c2701
Manfield JH, Yu KK-H, Efthimiou E et al (2017) Bariatric surgery or non-surgical weight loss for idiopathic intracranial hypertension? A systematic review and comparison of meta-analyses. Obes Surg 27:513–521. https://doi.org/10.1007/s11695-016-2467-7
Merola J, Selezneva L, Perkins R et al (2019) Cerebrospinal fluid diversion versus bariatric surgery in the management of idiopathic intracranial hypertension. Br J Neurosurg. https://doi.org/10.1080/02688697.2019.1698012
NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP et al (2014) Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA 311:1641–1651. https://doi.org/10.1001/jama.2014.3312
Ball AK, Howman A, Wheatley K et al (2011) A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neurol 258:874–881. https://doi.org/10.1007/s00415-010-5861-4
Piper RJ, Kalyvas AV, Young AM et al (2015) Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003434.pub3
ten Hove MW, Friedman DI, Patel AD et al (2016) Safety and tolerability of acetazolamide in the idiopathic intracranial hypertension treatment trial. J Neuroophthalmol 36:13–19. https://doi.org/10.1097/WNO.0000000000000322
Celebisoy N, Gökçay F, Sirin H, Akyürekli O (2007) Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 116:322–327. https://doi.org/10.1111/j.1600-0404.2007.00905.x
Costello F, Skolnik K, Sarna J, Varughese R (2019) Respiratory complications associated with acetazolamide use in the management of idiopathic intracranial hypertension. J Neuroophthalmol. https://doi.org/10.1097/WNO.0000000000000813
McCarthy KD, Reed DJ (1974) The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 189:194–201
Panagopoulos GN, Deftereos SN, Tagaris GA, et al (2007) Octreotide: a therapeutic option for idiopathic intracranial hypertension. Neurol Neurophysiol Neurosci 1
Albuquerque FC, Dashti SR, Hu YC et al (2011) Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results. World Neurosurg 75:648–652. https://doi.org/10.1016/j.wneu.2010.11.012(discussion 592–595)
Alsuhaibani AH, Carter KD, Nerad JA, Lee AG (2011) Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology 118:412–414. https://doi.org/10.1016/j.ophtha.2010.06.025
Satti SR, Leishangthem L, Chaudry MI (2015) Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension. AJNR Am J Neuroradiol 36:1899–1904. https://doi.org/10.3174/ajnr.A4377
Fonseca PL, Rigamonti D, Miller NR, Subramanian PS (2014) Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion. Br J Ophthalmol 98:1360–1363. https://doi.org/10.1136/bjophthalmol-2014-304953
Sinclair AJ, Kuruvath S, Sen D et al (2011) Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia 31:1627–1633. https://doi.org/10.1177/0333102411423305
Friedman DI (2019) Contemporary management of the Pseudotumor cerebri syndrome. Expert Rev Neurother 19:881–893. https://doi.org/10.1080/14737175.2019.1660163
Surgical Idiopathic Intracranial Hypertension Treatment Trial—full text view - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03501966. Accessed 1 Dec 2019
Teleb MS, Cziep ME, Issa M et al (2015) Stenting and angioplasty for idiopathic intracranial hypertension: a case series with clinical, angiographic, ophthalmological, complication, and pressure reporting. J Neuroimaging 25:72–80
Lenck S, Vallée F, Labeyrie M-A et al (2017) Stenting of the lateral sinus in idiopathic intracranial hypertension according to the type of stenosis. Neurosurgery 80:393–400. https://doi.org/10.1227/NEU.0000000000001261
Teleb MS, Cziep ME, Lazzaro MA et al (2013) Idiopathic intracranial hypertension. A systematic analysis of transverse sinus stenting. Interv Neurol 2:132–143. https://doi.org/10.1159/000357503
Nicholson P, Lenck S, Kucharczyk W, Mendes-Pereira V (2019) Dynamic nature of intracranial venous sinuses in idiopathic intracranial hypertension. Interv Neuroradiol. https://doi.org/10.1177/1591019919871393
Yan F, Rajah G, Ding Y et al (2019) Safety and efficacy of intravascular ultrasound as an adjunct to stenting for cerebral venous sinus stenosis-induced idiopathic intracranial hypertension: a pilot study. J Neurosurg. https://doi.org/10.3171/2018.11.JNS181885
Kalyvas AV, Hughes M, Koutsarnakis C et al (2017) Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature. Acta Neurochir (Wien) 159:33–49. https://doi.org/10.1007/s00701-016-3010-2
Huna-Baron R, Kupersmith MJ (2002) Idiopathic intracranial hypertension in pregnancy. J Neurol 249:1078–1081. https://doi.org/10.1007/s00415-002-0791-4
Kesler A, Kupferminc M (2013) Idiopathic intracranial hypertension and pregnancy. Clin Obstet Gynecol 56:389–396. https://doi.org/10.1097/GRF.0b013e31828f2701
Negro A, Delaruelle Z, Ivanova TA et al (2017) Headache and pregnancy: a systematic review. J Headache Pain. https://doi.org/10.1186/s10194-017-0816-0
Hilely A, Hecht I, Goldenberg-Cohen N, Leiba H (2019) Long-term follow-up of Pseudotumor cerebri syndrome in prepubertal children, adolescents, and adults. Pediatr Neurol. https://doi.org/10.1016/j.pediatrneurol.2019.04.018
Afonso CL, Talans A, Monteiro MLR (2015) Factors affecting visual loss and visual recovery in patients with Pseudotumor cerebri syndrome. Arq Bras Oftalmol 78:175–179. https://doi.org/10.5935/0004-2749.20150045
Tata G, Kisabay A, Gokcay F, Celebisoy N (2019) Idiopathic intracranial hypertension: are there predictors for visual outcome or recurrences? Clin Neurol Neurosurg 183:105378. https://doi.org/10.1016/j.clineuro.2019.105378
Pollak L, Zohar E, Glovinsky Y, Huna-Baron R (2013) Reevaluation of presentation and course of idiopathic intracranial hypertension–a large cohort comprehensive study. Acta Neurol Scand 127:406–412. https://doi.org/10.1111/ane.12060
Onyia CU, Ogunbameru IO, Dada OA et al (2019) Idiopathic intracranial hypertension: Proposal of a stratification strategy for monitoring risk of disease progression. Clin Neurol Neurosurg 179:35–41. https://doi.org/10.1016/j.clineuro.2019.02.013
Funding
This research received no external funding.
Author information
Authors and Affiliations
Contributions
Conceptualization, ST, MZ; literature search, ST; resources, ST, SLF, ER, CGC, FP, MZ; writing—original draft preparation, ST; critical revision: SLF, ER, CGC, FP, MZ; writing—review and editing, ST, MZ; visualization, SLF, ER, CGC, FP; supervision, SLF, FP, MZ. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Toscano, S., Lo Fermo, S., Reggio, E. et al. An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management. J Neurol 268, 3249–3268 (2021). https://doi.org/10.1007/s00415-020-09943-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-020-09943-9